A Rare Case of Granulomatous Hepatitis After Intravesical BCG Treatment

Abstract

Tumor recurrence following transurethral resection is common in non-muscle invasive urothelial cancers of the bladder. Intravesical Bacillus Calmette-Guerin (BCG) is frequently used in urology practice to prevent this recurrence and tumor progression. In this study, we present a case of Granulomatous Hepatitis that rarely develops during intravesical BCG application and that improved with anti-tuberculosis treatment. Abstract